[Pancreas scan (author's transl)].
A Review and a report of our ten years experience with pancreas scans. The diagnostic value of 75Selen-Methionine (75Se) scan is limited because of the lack of organ specificity of this substance. There is no improvement by pharmacological stimulation of the pancreas or subtraction techniques of the 75Se-activity in the liver. In the early phase after the injection of 75Se the distribution is more favourable for the pancreas compared to liver and intestine. Four descriptive terms are in use: normal, spotted, organ defect, and lack of uptake. There are no specific signs for pancreatitis, carcinoma, or exocrine dysfunction. Considering these limiting factors the use of pancreas scans is valuable to exclude pancreatic diseases.
D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008715:Methionine / Q000378:metabolism; D009928:Organ Specificity; D010179:Pancreas / Q000378:metabolism; D010182:Pancreatic Diseases / Q000175:diagnosis*; D010190:Pancreatic Neoplasms / Q000175:diagnosis; D010195:Pancreatitis / Q000175:diagnosis; D011868:Radioisotopes; D011877:Radionuclide Imaging; D012189:Retrospective Studies; D012643:Selenium / Q000378:metabolism; D013382:Subtraction Technique; D013997:Time Factors
D011868:Radioisotopes; D008715:Methionine; D012643:Selenium
Pankreasszintigraphie